Teva and Heptares enter $400m agreement for small-molecule migraine treatment
November 25, 2015Research and Development Heptares, Teva, collaboration, migraine
Teva Pharmaceuticals and Heptares Therapeutics have signed a licensing and drug-discovery agreement for Teva to gain exclusive global rights to …
UK commits £150 million to new Dementia Research Institute
November 25, 2015Research and Development dementia. R&D
The UK government has launched plans for a new £150 million dementia research institute that it says will drive a …
Bristol-Myers Squibb in new oncology collaboration
November 25, 2015Research and Development Bristol-Myers Squibb, collaboration, immuno-oncology, investment, venture capital
Bristol-Myers Squibb and European healthcare fund Life Sciences Partners are forming a strategic collaboration to identify breakthrough technologies. The companies …
PlaqueTec appoints Dr Nick West as CMO
November 24, 2015Research and Development PlaqueTec
PlaqueTec has appointed Dr Nick West as its new chief medical officer. Dr West is a research-active clinician with extensive …
FDA approves BMS’s Opdivo for renal cell carcinoma
November 24, 2015Research and Development
The FDA has approved Bristol Myers Squibb’s immunotherapy Opdivo for the treatment of patients with advanced renal cell carcinoma (RCC). …
Genmab pulls plug on Phase III Arzerra trial
November 24, 2015Manufacturing and Production, Research and Development Arzerra, Genmab, non-Hodgkin's lymphoma, non-Hodgkin’s lymphoma, ofatumumab, phase III, phase III failure
Genmab has stopped a Phase III study of its CD20-directed monoclonal antibody Arzerra, after it was shown to be unlikely …
Construction for new £55m cell and gene manufacturing centre in Stevenage begins
November 24, 2015Manufacturing and Production Catapult, Cell Therapy Catapult, Hertfordshire, gene therapy, manufacturing, stevenage
The Government-backed Cell Therapy Catapult has begun the construction for its cell and gene therapy manufacturing centre. The construction …
FDA approves Beximco to manufacture Carvedilol for US
November 24, 2015Manufacturing and Production Bangladesh, Beximco, Carvediol, FDA, exports, generics
Beximco Pharmaceuticals has become the first Bangladeshi pharma company to receive approval for a prescription drug to be manufactured in …
Novartis and Amgen drugs signed-off by European Commission
November 24, 2015Manufacturing and Production Amgen, Entresto, European Commission, Novartis, blincyto
The European governing body, the European Commission, has approved the Novartis drug Entresto for heart failure and Amgen’s Blincyto for …
Novo Nordisk to go green by 2020
November 24, 2015Manufacturing and Production Novo Nordish, manufacturing, production, renewable energy
Novo Nordisk has announced plans to go green in the next five years by using only electricity from renewable sources …
OmniaMed UK appoints new senior management
November 24, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
OmniaMed has strengthened its senior management team by appointing Dr Clive Deverson as managing director and Dr Colin Griffin as …
MSD launches new antibiotic in the UK
November 23, 2015Manufacturing and Production, Research and Development
Merck (MSD) has launched the new intravenous antibiotic Zerbaxa (ceftolozane/tazobactam) in the UK, for the treatment of complicated intra-abdominal infections …
Dr Clive Deverson
November 23, 2015OmniaMed UK appoints new senior management OmniaMed strengthens its senior management team by appointing Dr Clive Deverson as Managing Director …
Take the Pharmafocus reader survey today
November 23, 2015Manufacturing and Production, Research and Development
As a valued reader of Pharmafocus, you regularly receive print copies of our market-leading newspaper and have access to the digital …
Pfizer and Allergan confirm record $160 billion merger
November 23, 2015Manufacturing and Production, Research and Development
Pfizer and Allergan have confirmed a $160 billion merger, unanimously approved by their boards of directors, creating the world’s largest …
FDA approves Takeda’s Ninlaro for multiple myeloma
November 23, 2015Manufacturing and Production, Research and Development Takeda, myeloma
The US Food and Drug Administration (FDA) has approved Takeda’s Ninlaro (ixazomib) for use in combination with lenalidomide and dexamethasone …
Pfizer and Allergan on brink of $150 billion merger
November 23, 2015Sales and Marketing
Pfizer is reported to have secured formal board approval for a deal worth more than $150 billion to merge with …
Novartis bags two EU Cosentyx approvals
November 23, 2015Research and Development, Sales and Marketing
The European Commission (EC) has approved Novartis’ Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and …
Horizon withdraws $1bn Depomed bid
November 20, 2015Sales and Marketing
Horizon Pharma has withdrawn its $1 billion unsolicited offer for Depomed following a block from a California court based on Horizon’s inappropriate …
European Commission approves Amgen’s cancer drug Kyprolis in combo therapy
November 20, 2015Research and Development, Sales and Marketing
The European Commission (EC) has today granted marketing authorization for Amgen’s Kyprolis (carfilzomib) in combination with lenalidomide and dexamethasone for …
Latest content
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
